Conclusions: Short cervix in TTTS pregnancies is associated with adverse perinatal outcome with lower GA at delivery, higher rate of preterm delivery and lower neonatal survival of at least one twin. In our series, cerclage placement did not improve pregnancy outcome.
Objectives:
To evaluate the utility of cerebroplacental ratio (CPR) for prediction of subsequent fetal demise (FD) after fetoscopic laser photocoagulation of placental communication (FLP) in cases with Twin-twin transfusion (TTTS) or selective intrauterine growth restriction (sIUGR), complicated with absent end-diastolic flow in umbilical artery (UA-AEDF). Methods: FLP were performed from 2015 to 2017. CPR (MCA-PI/UA-PI) was recorded within 24 hours before FLP and postoperative 1, 4-7 or 9-15 days. Obstetrics and Gynecology, Maternal and Perinatal Care Centre, Seirei Hamamatsu General Hospital, Hamamatsu City, Japan; 3 Obstetrics and Perinatology, Seirei Hamamatsu General Hospital Maternal and Perinatal Care Centre, Hamamatsu, Shizuoka, Japan;  4 Division of Perinatology, Fetal Diagnosis and Therapy, Maternal and Perinatal Care Centre, Seirei Hamamatsu General Hospital, Hamamatsu City, Shizuoka, Japan Objectives: Single fetal demise (SD) occurs after laser therapy in 15-20% of twin pregnancies, with approximately 60% of cases occurring within a week after laser therapy. However, in some cases, SD occurs later than 14 days after laser therapy. The objective of this study was to elucidate whether the prognostic factors of SD after laser therapy for Twin-twin transfusion syndrome (TTTS) differ depending on the period of SD. Methods: We conducted a retrospective study on patients with monochorionic diamniotic (MCDA) twin pregnancies diagnosed with TTTS and treated with laser therapy at a single tertiary centre between 2007 and 2015. SD occurring within 14 days after laser therapy was defined as early SD (E-SD), and SD occurring later than 14 days after laser therapy as late SD (L-SD). In study 1, we defined the group of both twins alive on postoperative day 14 as the control group for E-SD. In study 2, we defined the group of both twins alive at 28 days old after birth as the control group for L-SD. We evaluated the prognostic factors associated with E-SD and L-SD after laser therapy separately, dividing the twins into donors and recipients. Results: Between 2007 and 2015, 145 pregnancies were diagnosed with TTTS and treated with laser therapy. SD occurred in 34 cases (24.1%), involving 26 donors (18.4%) and 8 recipients (5.7%). E-SD and L-SD occurred in 25 (73.5%) and 9 pregnancies (26.5%), respectively. Multivariable logistic regression analysis revealed that the independent risk factors of donor E-SD were the presence of arterioarterial anastomoses (odds ratio [OR], 11.1; 95% confidence interval [CI], 2.7-45.9); p = 0.001) and marginal cord insertion (OR, 4.7; 95% CI, 1.3-17.5); p = 0.022), and that of donor L-SD was postoperative umbilical artery reversed-end diastolic velocity in the donor (OR, 120; 95% CI, 3.9-3687; p = 0.006).
Conclusions:
We found that the prognostic factors of SD after laser therapy for TTTS differed depending on the period of SD in the donor.
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